ACADACADIA Pharmaceuticals Inc.

$29.57

What is the market doing?

What the tape says about ACAD

ACADIA Pharmaceuticals Inc. is +21% over the past year while the S&P 500 is +23%: 1.4 points behind the market.

+21%

1-year return · S&P 500 +23%

vs 200-day average
+23%

vs 200-day average · a clear uptrend

RSI (14)
57

RSI (14) · neutral

Below its 52-week high
−3.3%

Below its 52-week high

2024-08-06$14.10 – $30.58 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$29.57
1 monthS&P 500 +3.7%
+19%
1 yearS&P 500 +23%
+21%
5 yearsS&P 500 +87%
+41%
vs 50-day average$25.32
+17%
52-week high
$30.57
52-week low
$20.06
Annualised volatility
46%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$1.1M
Calendar-year price return
YearReturn
2026 (year to date)+11%
2025+46%
2024−41%
2023+97%
2022−32%
2021−56%
2020+25%
2019+165%
2018−46%
2017+4.4%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan104 of 10+3.8%
Feb107 of 10+3.3%
Mar101 of 10−13%
Apr103 of 10−7.8%
May105 of 10+3.3%
Jun106 of 10+1.7%
Jul117 of 11+4.5%
Aug115 of 11+0.32%
Sep104 of 10+3.2%
Oct105 of 10+0.56%
Nov106 of 10+5.4%
Dec106 of 10+6.3%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.